Literature DB >> 7458059

Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.

B G Nickerson, R J Lemen, C B Gerdes, M J Wegmann, G Robertson.   

Abstract

We studied 15 normal subjects and 15 patients with cystic fibrosis (CF), to determine the within-subject variability of spirometry, moment analysis, and slope ratios, and to calculate the per cent change for significance. Common sources of variability, such as patient and technician training, equipment errors, lung volume history, posture, and circadian variation, were controlled. Flow-time curves were analyzed with a digital computer. The coefficient of variations of spirometry were smallest for forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and peak flow (PF), and were largest for root moments (M) and slope ratios (SR) in both normal subjects and patients with CF. The coefficient of variations of all tests, except PF, were larger in patients with CF than in normal subjects. Significant change was calculated from the sample variance, mean, and the number of trials using a modified equation for sample size. This calculation estimated the degree of change for significance for each participant that was required in subsequent testing.

Entities:  

Mesh:

Year:  1980        PMID: 7458059     DOI: 10.1164/arrd.1980.122.6.859

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

Review 1.  HRCT imaging of airway responsiveness: effects of anesthetics.

Authors:  R H Brown
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 2.  Asthma in cystic fibrosis.

Authors:  Ian M Balfour-Lynn
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 3.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 4.  Airway reactivity in cystic fibrosis.

Authors:  R S Tepper; H Eigen
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Ultrasound-spirometry and capnography in horses: analysis of measurement reliability.

Authors:  C Herholz; R Straub; A Busato
Journal:  Vet Res Commun       Date:  2001-02       Impact factor: 2.459

6.  Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.

Authors:  I M Balfour-Lynn; N J Klein; R Dinwiddie
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

Review 7.  The epidemiological importance of intraindividual changes in objective pulmonary responses.

Authors:  M D Lebowitz; J Quackenboss; A E Camilli; D Bronnimann; C J Holberg; B Boyer
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

Review 8.  Human recombinant DNase in cystic fibrosis.

Authors:  A H Thomson
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

9.  Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits.

Authors:  P M Tweeddale; S Merchant; M Leslie; F Alexander; G J McHardy
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

10.  Random variation of inspiratory lung function parameters in patients with COPD: a diagnostic accuracy study.

Authors:  Frank J Visser; Sunil Ramlal; Ben Pelzer; P N Richard Dekhuijzen; Yvonne F Heijdra
Journal:  BMC Pulm Med       Date:  2010-05-14       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.